CN105213795A - A kind of Chinese medicinal formulae for the treatment of pernicious osteoma - Google Patents
A kind of Chinese medicinal formulae for the treatment of pernicious osteoma Download PDFInfo
- Publication number
- CN105213795A CN105213795A CN201510675800.8A CN201510675800A CN105213795A CN 105213795 A CN105213795 A CN 105213795A CN 201510675800 A CN201510675800 A CN 201510675800A CN 105213795 A CN105213795 A CN 105213795A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- fructus
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention provides a kind of Chinese medicinal formulae for the treatment of malignant bone tumor, it comprises following traditional Chinese medicine raw composition: Spina Gleditsiae, Radix Saposhnikoviae, Rhizoma Et Radix Notopterygii, the Radix Angelicae Dahuricae, Fructus Forsythiae, Radix Angelicae Sinensis, Olibanum, Myrrha, Flos Lonicerae, pollen, Radix Et Rhizoma Rhei, Radix Scutellariae, Herba Violae, the Pseudobulbus Bletillae (Rhizoma Bletillae), Fructus Arctii, Fructus Gardeniae, Bulbus Fritillariae Thunbergii, Scorpio, Squama Manis, Scolopendra, Herba Taraxaci, Radix Glycyrrhizae.Its Main Function stimulates human body to produce a kind of leukocyte, and this leukocyte can engulf the malignant cell on sclerotin, reaches the object for the treatment of malignant bone tumor.
Description
Technical field
The invention belongs to the category of leukocytes phagocytic method Therapeutic cancer, is one of Therapeutic cancer specific drug.Its Main Function stimulates human body to produce a kind of leukocyte, and this leukocyte can engulf the malignant cell on sclerotin, reaches the object for the treatment of pernicious osteoma.
Background technology
The latest data display that WHO relevant speciality mechanism of World Health Organization (WHO) issues, newly-increased cancer patient 1,410 ten thousand people in the whole world in 2012, cancer related mortality case reaches 8,200,000 examples, and this presents the trend of increase than ever.Along with the growth of population in the world and increasing the weight of gradually of aging degree, estimate that namely 2025 whole world will increase cases of cancer every year newly after 10 years and reach 1,930 ten thousand people, cases of cancer will be increased every year newly more than 2,400 ten thousand people to the whole world in 2035.According to China News Week on April 7th, 2013, Cancer in China present situation: every day 8550, people became cancer patient.That is China in 2012 increases cancer patient newly more than 3,070,000 people, and about 2,200,000 people die from cancer, and it is very urgent therefore to capture cancer.At present, the whole world only has cancer therapy drug, does not have the specific drug of Therapeutic cancer.
Cancerous cell is generated through gene mutation by normal cell, and therefore its cellularity, physiologically active etc. are about the same with normal cell.Therefore while extraneous medicine kills cancerous cell, normal cell can be killed too, and this is also the reason that western medicine cannot capture cancer.All the time there is tumor cell to produce in human body, but be not that everyone can cancer stricken.It will be argued that, the not cancered reason of normal person be newly-generated tumor cell engulf by the leukocyte in human body, the best bet of Therapeutic cancer allows patient on medication, stimulates the leukocytes phagocytic cancerous cell required for human body generation to reach the object of Therapeutic cancer.
Leukocytes phagocytic foreign body has the feature of uniqueness.Containing a large amount of leukocyte in blood of human body, it will be argued that all leukocyte all have phagocytic activity, the leukocyte not showing phagocytic activity be because its object engulfed in human body not.Cancerous cell is positioned at human body different tissues and organ shows different shapes, optimum and perniciously shows as different shapes, and I calls " chameleon " characteristic this phenomenon.Leukocytes phagocytic foreign body has uniqueness, and therefore same cancerous cell is positioned at different tissues or organ needs different types of leukocyte just can engulf.According to engulfing object classification, leukocyte can be divided into several thousand kind, even more.The leukocyte can engulfing cancerous cell also has several ten kinds, even hundreds of.Therefore the specific drug of Therapeutic cancer needs number ten kinds, even hundreds of.
Summary of the invention
The present invention is a kind of Chinese medicinal formulae for the treatment of pernicious osteoma, the raw material of Chinese medicine comprising following composition by weight is made: Spina Gleditsiae 40 parts-80 parts, Radix Saposhnikoviae 70 parts-130 parts, Rhizoma Et Radix Notopterygii 70 parts-130 parts, the Radix Angelicae Dahuricae 70 parts-130 parts, Fructus Forsythiae 70 parts-130 parts, Radix Angelicae Sinensis 70 parts-130 parts, Olibanum 70 parts-130 parts, Myrrha 70 parts-130 parts, Flos Lonicerae 150 parts-250 parts, pollen 70 parts-130 parts, Radix Et Rhizoma Rhei 40 parts-80 parts, Radix Scutellariae 70 parts-130 parts, Herba Violae 70 parts-130 parts, the Pseudobulbus Bletillae (Rhizoma Bletillae) 70 parts-130 parts, Fructus Arctii 70 parts-130 parts, Fructus Gardeniae 70 parts-130 parts, Bulbus Fritillariae Thunbergii 70 parts-130 parts, Scorpio 40 parts-80 parts, Squama Manis 70 parts-130 parts (preferably breaking into powdery), Scolopendra 7-13, Herba Taraxaci 40 parts-80 parts, 40 parts-80 parts, Radix Glycyrrhizae.
Preferably, each Chinese medicine composition by weight is: Spina Gleditsiae 50 parts-70 parts, Radix Saposhnikoviae 90 parts-110 parts, Rhizoma Et Radix Notopterygii 90 parts-110 parts, the Radix Angelicae Dahuricae 90 parts-110 parts, Fructus Forsythiae 90 parts-110 parts, Radix Angelicae Sinensis 90 parts-110 parts, Olibanum 90 parts-110 parts, Myrrha 90 parts-110 parts, Flos Lonicerae 180 parts-220 parts, pollen 90 parts-110 parts, Radix Et Rhizoma Rhei 50 parts-70 parts, Radix Scutellariae 90 parts-110 parts, Herba Violae 90 parts-110 parts, the Pseudobulbus Bletillae (Rhizoma Bletillae) 90 parts-110 parts, Fructus Arctii 90 parts-110 parts, Fructus Gardeniae 90 parts-110 parts, Bulbus Fritillariae Thunbergii 90 parts-110 parts, Scorpio 50 parts-70 parts, Squama Manis 90 parts-110 parts (preferably breaking into powdery), Scolopendra 9-11, Herba Taraxaci 50 parts-70 parts, 50 parts-70 parts, Radix Glycyrrhizae.
Preferably, each Chinese medicine composition by weight is: Spina Gleditsiae 60 parts, Radix Saposhnikoviae 100 parts, Rhizoma Et Radix Notopterygii 100 parts, the Radix Angelicae Dahuricae 100 parts, Fructus Forsythiae 100 parts, Radix Angelicae Sinensis 100 parts, Olibanum 100 parts, Myrrha 100 parts, Flos Lonicerae 200 parts, pollen 100 parts, Radix Et Rhizoma Rhei 60 parts, Radix Scutellariae 100 parts, Herba Violae 100 parts, the Pseudobulbus Bletillae (Rhizoma Bletillae) 100 parts, Fructus Arctii 100 parts, Fructus Gardeniae 100 parts, Bulbus Fritillariae Thunbergii 100 parts, Scorpio 60 parts, Squama Manis 100 parts (preferably breaking into powdery), Scolopendra 10, Herba Taraxaci 60 parts, 60 parts, Radix Glycyrrhizae.
Constitutional osteoma is very hard, and pernicious osteoma cell very easily spreads.After patient on medication, stimulate the cancerous cell on a large amount of required leukocytes phagocytic sclerotin of human body generation, patient feels that the pus that leukocytes phagocytic cancerous cell is formed sprays just as fountain from periosteum aperture.Entire patient gives out urine smell foul odour (for this abnormal smells from the patient, I feels it is raw meat sometimes, sometimes be shy, sometimes be smelly, feel sometimes acid acid, feel pleasantly sweet sometimes, have time image smell of petrol, the eyes also stimulating people had, the taste much cannot said in addition).Thorough radical cure primary bone cancer needs several cycle, in 15 days each cycles, wherein within first 12 days, engulfs the cancerous cell on sclerotin, within latter three days, engulfs the cancerous cell spread from sclerotin.This process time is longer, needs a large amount of Leukocytopoiesis in this process, the physical ability that needs of patients consumption is a large amount of.If the physical ability of patient is not enough, just there will be heart, kidney failure, cause death.Therefore sufficient physical ability must be ensured in the process for the treatment of of cancer, to avoid the generation of tragedy.This is again a very important medical science problem.The number of times of drug administration will be determined according to the size of malignant tumor on sclerotin in patient body, when pernicious osteoma is less, or the pernicious osteoma that cancerous cell diffuses to form, under the prerequisite ensureing dieting, when entire patient does not have urine smell foul smell to shed, just this medicine can be cut out.Generally, for idiopathic pernicious osteoma, when patient takes all after dates of this medicine three to five, the skin around osteoma starts decortication.When after skin peeling three layers, pus is mingled with the constraint that tumor mass will break through skin, and directly excrete, in the traditional Chinese medical science that Here it is, said tumor goes out " head ".For this " head ", we must carry out safety precaution, avoid the infection being subject to pathogenic bacteria etc.When pus is no longer discharged from this, this " head " also can slowly heal, and patient just can cut out this medicine.If patient's physical ability is not enough, tumor cannot go out " head ", and doctor will try every possible means to allow tumor go out " head ".Otherwise, pus be mingled with tumor mass once enter inside of human body tissue, patient just there will be edema from hands or foot, and upwards develops fast, and heart, kidney also there will be exhaustion, after three, four days patient will death.
In order to ensure in cancer treatment procedure, human body can produce the leukocyte of needs, therefore within each one day, must aviod certain food in drug administration process and before and after taking medicine.Examining and conscientiously studying according to me, the food of dieting comprises: milk and the milk fishes such as milk, sheep milk, milk powder, toffee; The meat products such as beef, Carnis caprae seu ovis, kind Carnis Sus domestica, one's old mother's Carnis Sus domestica; Vegetable and the flavoring agent such as Fructus Capsici, Capsicum annuum L., long capsicum, Tonnae Sinensis, Fructus Piperis, Pericarpium Zanthoxyli; Aquatic products and the Thallus Laminariae (Thallus Eckloniae)s, zostera marina, Cipangopaludina chinensis, Carnis Rapanae thomasianae etc. such as the fish Trionyx sinensis Wiegmann shrimp Eriocheir sinensis in rivers,lakes and seas; The alcohol products etc. such as Chinese liquor, yellow wine, medicated beer, red wine.Because different regions people have different types of food and different dietary habit, therefore in the process of Therapeutic cancer, also have a lot of food needing dieting, need us to go to identify and find in research from now on.
Detailed description of the invention
The present invention is a kind of Chinese medicinal formulae for the treatment of malignant bone tumor, the raw material of Chinese medicine comprising following composition by weight is made: Spina Gleditsiae 40 parts-80 parts, Radix Saposhnikoviae 70 parts-130 parts, Rhizoma Et Radix Notopterygii 70 parts-130 parts, the Radix Angelicae Dahuricae 70 parts-130 parts, Fructus Forsythiae 70 parts-130 parts, Radix Angelicae Sinensis 70 parts-130 parts, Olibanum 70 parts-130 parts, Myrrha 70 parts-130 parts, Flos Lonicerae 150 parts-250 parts, pollen 70 parts-130 parts, Radix Et Rhizoma Rhei 40 parts-80 parts, Radix Scutellariae 70 parts-130 parts, Herba Violae 70 parts-130 parts, the Pseudobulbus Bletillae (Rhizoma Bletillae) 70 parts-130 parts, Fructus Arctii 70 parts-130 parts, Fructus Gardeniae 70 parts-130 parts, Bulbus Fritillariae Thunbergii 70 parts-130 parts, Scorpio 40 parts-80 parts, Squama Manis 70 parts-130 parts (preferably breaking into powdery), Scolopendra 7-13, Herba Taraxaci 40 parts-80 parts, 40 parts-80 parts, Radix Glycyrrhizae.
Preferably, each Chinese medicine composition by weight is: Spina Gleditsiae 50 parts-70 parts, Radix Saposhnikoviae 90 parts-110 parts, Rhizoma Et Radix Notopterygii 90 parts-110 parts, the Radix Angelicae Dahuricae 90 parts-110 parts, Fructus Forsythiae 90 parts-110 parts, Radix Angelicae Sinensis 90 parts-110 parts, Olibanum 90 parts-110 parts, Myrrha 90 parts-110 parts, Flos Lonicerae 180 parts-220 parts, pollen 90 parts-110 parts, Radix Et Rhizoma Rhei 50 parts-70 parts, Radix Scutellariae 90 parts-110 parts, Herba Violae 90 parts-110 parts, the Pseudobulbus Bletillae (Rhizoma Bletillae) 90 parts-110 parts, Fructus Arctii 90 parts-110 parts, Fructus Gardeniae 90 parts-110 parts, Bulbus Fritillariae Thunbergii 90 parts-110 parts, Scorpio 50 parts-70 parts, Squama Manis 90 parts-110 parts (preferably breaking into powdery), Scolopendra 9-11, Herba Taraxaci 50 parts-70 parts, 50 parts-70 parts, Radix Glycyrrhizae.
Preferably, each Chinese medicine composition by weight is: Spina Gleditsiae 60 parts, Radix Saposhnikoviae 100 parts, Rhizoma Et Radix Notopterygii 100 parts, the Radix Angelicae Dahuricae 100 parts, Fructus Forsythiae 100 parts, Radix Angelicae Sinensis 100 parts, Olibanum 100 parts, Myrrha 100 parts, Flos Lonicerae 200 parts, pollen 100 parts, Radix Et Rhizoma Rhei 60 parts, Radix Scutellariae 100 parts, Herba Violae 100 parts, the Pseudobulbus Bletillae (Rhizoma Bletillae) 100 parts, Fructus Arctii 100 parts, Fructus Gardeniae 100 parts, Bulbus Fritillariae Thunbergii 100 parts, Scorpio 60 parts, Squama Manis 100 parts (preferably breaking into powdery), Scolopendra 10, Herba Taraxaci 60 parts, 60 parts, Radix Glycyrrhizae.
The most original method is decocted with water by the raw material of Chinese medicine of above-mentioned components by weight percent, and first time decocts 45-50 minute, and second time decocts 35-40 minute, and third time decocts 25-30 minute, decocts three times altogether.Decoct three times the Chinese drugs agentia mixing obtained, be divided into 30 parts, patient 2 times on the one, i.e. each 1 part of morning and evening.The number of times of drug administration will be determined according to the size of malignant tumor on sclerotin in patient body, when pernicious osteoma is less, or the pernicious osteoma that cancerous cell diffuses to form, under the prerequisite ensureing dieting, when entire patient does not have urine smell foul smell to shed, just this medicine can be cut out.
The present invention is not limited to above-mentioned preferred forms, and other modes that it can describe to be much different from this are implemented.Anyone can draw other various forms of products under enlightenment of the present invention, no matter but make any change in its shape or structure, every have identical with the application or akin technical scheme, all drops within protection scope of the present invention.
Illustrate: above said patient be University Of Qingdao school Master degree candidate, be about to graduation.
This patient once arrived Qingdao 401 hospital in April, 2005, was misdiagnosed as leg and suffered from cold, and took the medicine of relaxing muscles and tendons to promote blood circulation, without any effect.
This patient once arrived Jiangzhou, Qingdao City central hospital in early June, 2005, by CT examination, was misdiagnosed as periosteum inflammation, beat transfusion bottle in hospital about 20 days, used various antibiotic medicine without any effect.
This patient once arrived Hospital Attached to Medical College, Qingdao Univ. on July 23rd, 2005, and be diagnosed as osteosarcoma and chondrosarcoma by magnetic resonance examination, cancerous cell is diffused into whole body, and this hospital does not have ability thoroughly to cure.
Claims (4)
1. the present invention is a kind of Chinese medicinal formulae for the treatment of malignant bone tumor, the raw material of Chinese medicine comprising following composition by weight is made: Spina Gleditsiae 40 parts-80 parts, Radix Saposhnikoviae 70 parts-130 parts, Rhizoma Et Radix Notopterygii 70 parts-130 parts, the Radix Angelicae Dahuricae 70 parts-130 parts, Fructus Forsythiae 70 parts-130 parts, Radix Angelicae Sinensis 70 parts-130 parts, Olibanum 70 parts-130 parts, Myrrha 70 parts-130 parts, Flos Lonicerae 150 parts-250 parts, pollen 70 parts-130 parts, Radix Et Rhizoma Rhei 40 parts-80 parts, Radix Scutellariae 70 parts-130 parts, Herba Violae 70 parts-130 parts, the Pseudobulbus Bletillae (Rhizoma Bletillae) 70 parts-130 parts, Fructus Arctii 70 parts-130 parts, Fructus Gardeniae 70 parts-130 parts, Bulbus Fritillariae Thunbergii 70 parts-130 parts, Scorpio 40 parts-80 parts, Squama Manis 70 parts-130 parts (preferably breaking into powdery), Scolopendra 7-13, Herba Taraxaci 40 parts-80 parts, 40 parts-80 parts, Radix Glycyrrhizae.
2. according to described in claim 1, a kind of Chinese medicinal formulae for the treatment of malignant bone tumor, it is characterized in that, each raw material of Chinese medicine composition by weight is: Spina Gleditsiae 50 parts-70 parts, Radix Saposhnikoviae 90 parts-110 parts, Rhizoma Et Radix Notopterygii 90 parts-110 parts, the Radix Angelicae Dahuricae 90 parts-110 parts, Fructus Forsythiae 90 parts-110 parts, Radix Angelicae Sinensis 90 parts-110 parts, Olibanum 90 parts-110 parts, Myrrha 90 parts-110 parts, Flos Lonicerae 180 parts-220 parts, pollen 90 parts-110 parts, Radix Et Rhizoma Rhei 50 parts-70 parts, Radix Scutellariae 90 parts-110 parts, Herba Violae 90 parts-110 parts, the Pseudobulbus Bletillae (Rhizoma Bletillae) 90 parts-110 parts, Fructus Arctii 90 parts-110 parts, Fructus Gardeniae 90 parts-110 parts, Bulbus Fritillariae Thunbergii 90 parts-110 parts, Scorpio 50 parts-70 parts, Squama Manis 90 parts-110 parts (preferably breaking into powdery), Scolopendra 9-11, Herba Taraxaci 50 parts-70 parts, 50 parts-70 parts, Radix Glycyrrhizae.
3. according to described in claim 1, a kind of Chinese medicinal formulae for the treatment of malignant bone tumor, it is characterized in that, each raw material of Chinese medicine composition by weight is: Spina Gleditsiae 60 parts, Radix Saposhnikoviae 100 parts, Rhizoma Et Radix Notopterygii 100 parts, the Radix Angelicae Dahuricae 100 parts, Fructus Forsythiae 100 parts, Radix Angelicae Sinensis 100 parts, Olibanum 100 parts, Myrrha 100 parts, Flos Lonicerae 200 parts, pollen 100 parts, Radix Et Rhizoma Rhei 60 parts, Radix Scutellariae 100 parts, Herba Violae 100 parts, the Pseudobulbus Bletillae (Rhizoma Bletillae) 100 parts, Fructus Arctii 100 parts, Fructus Gardeniae 100 parts, Bulbus Fritillariae Thunbergii 100 parts, Scorpio 60 parts, Squama Manis 100 parts (preferably breaking into powdery), Scolopendra 10, Herba Taraxaci 60 parts, 60 parts, Radix Glycyrrhizae.
4. the most original method is decocted with water by the raw material of Chinese medicine of above-mentioned composition by weight, and first time decocts 45-50 minute, and second time decocts 35-40 minute, and third time decocts 25-30 minute, decocts three times altogether; Decoct three times the Chinese drugs agentia mixing obtained, be divided into 30 parts, patient 2 times on the one, namely sooner or later respectively take 1 part; The number of times taking this medicine will be determined according to the size of malignant bone tumor on sclerotin in patient body, under the prerequisite ensureing dieting, when entire patient does not have urine smell foul smell to shed, that is sclerotin does not have cancerous cell to be engulfed, just can cut out this medicine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510675800.8A CN105213795A (en) | 2015-10-15 | 2015-10-15 | A kind of Chinese medicinal formulae for the treatment of pernicious osteoma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510675800.8A CN105213795A (en) | 2015-10-15 | 2015-10-15 | A kind of Chinese medicinal formulae for the treatment of pernicious osteoma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105213795A true CN105213795A (en) | 2016-01-06 |
Family
ID=54983307
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510675800.8A Pending CN105213795A (en) | 2015-10-15 | 2015-10-15 | A kind of Chinese medicinal formulae for the treatment of pernicious osteoma |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105213795A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115814023A (en) * | 2022-08-10 | 2023-03-21 | 胶州市盛福中医诊所店 | Traditional Chinese medicine composition for cancer cells |
-
2015
- 2015-10-15 CN CN201510675800.8A patent/CN105213795A/en active Pending
Non-Patent Citations (1)
| Title |
|---|
| 王袭柞等: "《中医外科病诊治彩色图谱》", 31 December 1992, 山东科学技术出版社 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115814023A (en) * | 2022-08-10 | 2023-03-21 | 胶州市盛福中医诊所店 | Traditional Chinese medicine composition for cancer cells |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104257817B (en) | A kind of Chinese medicine preparation for gut purge intestinal lavage | |
| CN105497620A (en) | Health-care traditional Chinese medicine preparation for weight reduction and body building | |
| CN111743934A (en) | Traditional Chinese medicine composition for regulating intestinal flora and application thereof | |
| CN104524396A (en) | Traditional Chinese medicine preparation for health care | |
| CN105232986A (en) | Chinese medicinal prescription for treating malignant chondroma | |
| CN105213795A (en) | A kind of Chinese medicinal formulae for the treatment of pernicious osteoma | |
| CN105104887A (en) | Cattle compound feed and preparation method thereof | |
| CN104524464A (en) | Traditional Chinese medicine preparation for treating hyperactivity and preparation method of traditional Chinese medicine preparation | |
| CN106177651A (en) | A kind of infantile malnutrition medicine | |
| CN103285192A (en) | Traditional Chinese medicine preparation for treating epilepsy | |
| CN105125914A (en) | Traditional Chinese medicine for expelling toxins | |
| CN105267300A (en) | Acne removing traditional Chinese medicine composition | |
| CN104688999A (en) | Chinese herbal preparation for immunity enhancement | |
| CN1259953C (en) | Anti aging health caring medicine | |
| CN108967980A (en) | A kind of food granules of prevention and treatment toxoplasmosis | |
| CN103222655B (en) | Yellow spot-removing apple vinegar health-care beverage and preparation method thereof | |
| CN104069062B (en) | Hilicidum injection for preventing and treating ischemic cardiovascular and cerebrovascular diseases as well as preparation method and application thereof | |
| CN105125872A (en) | Traditional Chinese medicinal formula for treating benign osteoma | |
| CN107137663A (en) | One kind treats carcinoid Chinese medicinal formulae in gall-bladder | |
| CN106389577A (en) | Traditional Chinese medicine composition capable of blackening and brightening hair | |
| CN105998843A (en) | Traditional Chinese medicine preparation for treating recurring type dental ulcers | |
| CN106307502A (en) | Diet for treating acnes and improving skin textures | |
| CN104666582B (en) | A kind of health products preparation method and corresponding health products for strengthen immunity | |
| CN106266526A (en) | A kind of Chinese patent medicine treating part spot | |
| CN105582298A (en) | Preparation capable of enhancing body immunity and preparation method of preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160106 |